COSMO Pharmaceuticals N.V.
COPN | SW
Overview
Corporate Details
- ISIN(s):
- NL0011832936
- LEI:
- 724500OX0EBQRYTVV639
- Country:
- Netherlands (Kingdom of the)
- Address:
- Sir Rogerson's Quay Riverside II, Dublin 2 Dublin
- Website:
- https://www.cosmopharma.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
COSMO Pharmaceuticals N.V. is a specialty pharmaceutical company focusing on innovative therapies for gastrointestinal diseases and specialty treatments.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-08-08 02:00 |
Regulatory News Service
Cosmo and Takeda Renew Strategic Manufacturing Agreement for Global Supply of O…
|
English | 4.7 KB | |
| 2025-08-08 02:00 |
M&A Activity
Cosmo und Takeda verlängern ihre strategische Produktionsvereinbarung für die w…
|
German | 5.0 KB | |
| 2025-08-06 02:00 |
Business and Financial Review
Cosmo Pharmaceuticals Confirms No Exposure to Proposed U.S. Tariffs and Reaffir…
|
English | 3.3 KB | |
| 2025-08-06 02:00 |
Earnings Release
Cosmo Pharmaceuticals bestätigt, dass keine Auswirkungen durch geplante US-Zöll…
|
German | 4.0 KB | |
| 2025-07-23 02:00 |
Earnings Release
Cosmo Delivers Strong Performance in H1 2025, Raises Full-Year EBITDA Guidance …
|
English | 22.3 KB | |
| 2025-07-23 02:00 |
Earnings Release
Cosmo liefert starke Ergebnisse im ersten Halbjahr 2025, erhöht EBITDA-Guidance…
|
German | 24.4 KB | |
| 2025-07-17 02:00 |
Regulatory News Service
Cosmo announces launch of Winlevi® for Treatment of Acne in Singapore and Malay…
|
English | 9.5 KB | |
| 2025-07-17 02:00 |
Regulatory News Service
Cosmo: Markteinführung von Winlevi® zur Behandlung von Akne in Singapur und Mal…
|
German | 10.7 KB | |
| 2025-07-16 02:00 |
Environmental & Social Information
Cosmo Accelerates Global ESG Leadership with Major Ratings Upgrades, UN Compact…
|
English | 6.4 KB | |
| 2025-07-16 02:00 |
Environmental & Social Information
Cosmo baut Vorreiterrolle im Bereich ESG durch bedeutende Rating-Upgrades, die …
|
German | 7.4 KB | |
| 2025-07-01 02:00 |
Investor Presentation
Cosmo Unveils Bold 2030 Vision and Strategy; launches AI-driven Growth Phase at…
|
English | 8.4 KB | |
| 2025-07-01 02:00 |
Investor Presentation
Cosmo präsentiert mutige Vision und Strategie für 2030 und leitet am Investoren…
|
German | 9.5 KB | |
| 2025-06-25 02:00 |
M&A Activity
Cosmo Announces Sale of “Digital Trust” in Strategic Portfolio Streamlining Move
|
English | 6.8 KB | |
| 2025-06-25 02:00 |
M&A Activity
Cosmo gibt Verkauf von «Digital Trust» im Rahmen einer strategischen Portfolio-…
|
German | 7.4 KB | |
| 2025-06-24 02:00 |
Regulatory News Service
Cosmo to Unveil First-of-its-Kind Clinical Study on the Use of GI Genius™ with …
|
English | 8.7 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
Biotika A.S. | Slovakia | BSL | |
|
Bio Vitos Pharma AB | Sweden | BIOVIT | |
|
BOIRON | France | BOI | |
|
Bonyf N.V. | Belgium | MLBON | |
|
Bosnalijek d.d. Sarajevo | Bosnia and Herzegovina | BSNL | |
| BrightPath Biotherapeutics Co., Ltd. | Japan | 4594 | ||
|
Calliditas Therapeutics | Sweden | CALTX | |
|
Camurus | Sweden | CAMX | |
| CanBas Co.,Ltd. | Japan | 4575 | ||
|
Cannabotech Ltd. | Israel | CNTC |